Pressure BioSciences' Revenues Improve 9 Percent in Q1 | GenomeWeb

NEW YORK (GenomeWeb) – Pressure BioSciences today reported its first quarter revenues were up 9 percent year over year despite not recording any grant revenues in the recently completed quarter.

For the three months ended March 31, the South Easton, Mass.-based firm posted $404,147 in revenues, up from $370,737 a year ago. While it had no grant revenues in Q1 2014, compared to $149,168 a year ago, revenues generated from the sales of its products and services and other revenues grew 82 percent to $404,147 from $221,569.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.